Sibel Slavsky

Sibel Slavsky is a seasoned professional in oncology clinical science, currently serving as Director at Ascendis Pharma since March 2021, after previously holding the role of Associate Director. Prior experience includes significant contributions at Nektar Therapeutics from July 2014 to March 2021, where Sibel progressed through various roles, including Sr. Clinical Scientist in Clinical Development and several positions in Clinical Data Management. Sibel's expertise originated at Exelixis as a Clinical Data Manager and further developed at Gilead Sciences as a Clinical Data Associate I, primarily focusing on hepatitis C trials. Sibel also has a background in managing data for GU Oncology clinical trials at Stanford Cancer Center. Sibel's educational foundation is a Bachelor of Science in General Biology from UC San Diego.